Changing aetiology of liver dysfunction in the new generation of a hepatitis B and C-endemic area: Cross-sectional studies on adolescents born in the first 10 years after universal hepatitis B vaccination

Liver International

Volumn 28, Issue 9, 2008, Pages 1298-1304

  Kao, Jung Ta ^a   Wang, Jing Houng ^a   Hung, Chao Hung ^a   Hu, Tsung Hui ^a   Lee, Chuan Mo ^a   Hung, Shu Fen ^a   Lu, Sheng Nan ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Abnormal liver function; Hepatitis B and C viruses; Obesity; Taiwanese adolescents

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; HEPATITIS C ANTIBODY; VIRUS RNA;

ADOLESCENT; ADOLESCENT HEALTH; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ECHOGRAPHY; ENDEMIC DISEASE; FATTY LIVER; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION RISK; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MASS IMMUNIZATION; NONHUMAN; OBESITY; PREVALENCE; SEROPREVALENCE; SEX DIFFERENCE; TREND STUDY;

ADOLESCENT; ALANINE TRANSAMINASE; BODY MASS INDEX; CHILD; CROSS-SECTIONAL STUDIES; ENDEMIC DISEASES; FEMALE; HEPATITIS B; HEPATITIS B VACCINES; HEPATITIS C; HUMANS; LIVER DISEASES; MALE; OBESITY; PREVALENCE; TAIWAN;

EID: 51649129103     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01844.x     Document Type: Article

References (37)

1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004; 11: 97-107.
2. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006; 45: 529-38.
3. Mast EE, Weinbaum CM, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: Immunization of adults. Morbid Mortal Weekly Rep Recomm Rep 2006; 55: 1-33.
4. CDC. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Morbid Mortal Weekly Rep Recomm Rep 1998; 47: 1-39.
5. Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol 2006; 40: 5-10.
6. Rashid M, Roberts EA. Nonalcoholic steatohepatitis in children. J Pediatr Gastro Nutr 2000; 30: 48-53.
7. Health and National Health Insurance Annual Statistics Information Service, Taiwan. http://www.doh.gov.tw/statistic/ [Accessed in Jan. 2008].
8. Raza SA, Clifford GM, Franceschi S. Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: A systematic review. Br J Cancer 2007; 96: 1127-34.
9. Chen CH, Yang PM, Huang GT, Lee HS, Sung SL, Sheu JC. Estimation of prevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants. J Formos Med Assoc 2007; 106: 148-55.
10. Ni YH, Chang MH, Huang LM, et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 2001; 135: 796-800.
11. Wang JT, Wang TH, Lin JT, Lee CZ, Sheu JC, Chen DS. Effect of hepatitis C antibody screening in blood donors on post-transfusion hepatitis in Taiwan. J Gastroenterol Hepatol 1995; 10: 454-8.
12. Hsieh PL, FitzGerald M. Childhood obesity in Taiwan: Review of the Taiwanese literature. Nurs Health Sci 2005; 7: 134-42.
13. Tsai PY, Yen CJ, Li YC, Chiu TY, Chen CY, Jan CF. Association between abnormal liver function and risk factors for metabolic syndrome among freshmen. J Adolesc Health 2007; 41: 132-7.
14. Flynn MA, McNeil DA, Maloff B, et al. Reducing obesity and related chronic disease risk in children and youth: A synthesis of evidence with 'best practice' recommendations. Obes Rev 2006; 7: 7-66.
15. Lu SN, Wang JH, Kuo YK, et al. Predicting the prevalence of antibody to hepatitis C virus (HCV) in a community by the prevalence of elevated levels of alanine aminotransferase: A method to identify areas endemic for HCV. Am J Trop Med Hyg 2002; 67: 145-50.
16. Yajima Y, Ohta K, Narui T, Abe R, Suzuki H, Ohtsuki M. Ultrasonographical diagnosis of fatty liver: Significance of the liver-kidney contrast. Tohoku J Exp Med 1983; 139: 43-50.
17. Huang HC, Huang YS, Wu JC, et al. Characteristics of autoimmune hepatitis in Taiwan: The 11 years' experiences of a medical center. Zhonghua Yi Xue Za Zhi 2002; 65: 563-9.
18. Sternlieb I. Perspectives on Wilson's disease. Hepatology 1990; 12: 1234-9.
19. Chen HL, Chang MH, Ni YH, et al. Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan. JAMA 1996; 276: 906-8.
20. Lu SN, Chen CH, Chen TM, et al. Hepatitis B virus infection in adolescents in a rural township-15 years subsequent to mass hepatitis B vaccination in Taiwan. Vaccine 2006; 24: 759-65.
21. Huang JF, Lu SN, Chue PY, et al. Hepatitis C virus infection among teenagers in an endemic township in Taiwan: Epidemiological and clinical follow-up studies. Epidemiol Infect 2001; 127: 485-92.
22. Lu SN, Chen HC, Tang CM, et al. Prevalence and manifestations of hepatitis C seropositivity in children in an endemic area. Pediatr Infect Dis J 1998; 17: 142-5.
23. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144: 705-14.
24. Lee PL, Wang JH, Tung HD, Lee CM, Lu SN. A higher than expected recovery rate from hepatitis C infection amongst adolescents: A community study in a hepatitis C-endemic township in Taiwan. Trans R Soc Trop Med Hyg 2004; 98: 367-72.
25. Moranska I, Jurczyk K, Klosinska E, et al. Relationship of serum alanine aminotransferase (ALT) to body weight, age and sex in blood donors population. Wiad Lek 2004; 57: 427-30.
26. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: From steatosis to cirrhosis. Hepatology 2006; 43: 99-112.
27. Chan DF, Li AM, Chu WC, et al. Hepatic steatosis in obese Chinese children. Int J Obes Relat Metab Disord 2004; 28: 1257-63.
28. Del Gaudio A, Boschi L, Del Gaudio GA, Mastrangelo L, Munari D. Liver damage in obese patients. Obes Surg 2002; 12: 802-4.
29. Strauss RS, Barlow SE, Dietz WH. Prevalence of abnormal serum aminotransferases values in overweight and obese adolescents. J Pediatr 2000; 136: 727-33.
30. Lobstein T, Baur L, Uauy R. IASO International Obesity TaskForce. Obesity in children and young people: A crisis in public health. Obes Rev 2004; 5: 4-104.
31. Bener A. Prevalence of obesity, overweight, and underweight in Qatari adolescents. Food Nutr Bull 2006; 27: 39-45.
32. Lin YC, Hsiao ST, Chen JD. Sonographic fatty liver and hepatitis B virus carrier status: Synergistic effect on liver damage in Taiwanese adults. World J Gastroenterol 2007; 13: 1805-10.
33. Chang WY, Chen CJ, Lu SN, et al. Relationship between fatty liver, alanine aminotransferase, HBsAg and hepatitis C virus. J Gastroenterol Hepatol 1992; 7: 455-8.
34. Hye SP, Jee HH, Kyung MC, Seon MK. Relation between elevated serum alanine aminotransferase and metabolic syndrome in Korean adolescents. Am J Clin Nutr 2005; 82: 1046-51.
35. de Ledinghen V, Combes M, Trouette H, et al. Should a liver biopsy be done in patients with subclinical chronically elevated transaminases? Eur J Gastroenterol Hepatol 2004; 16: 879-83.
36. Satapathy SK, Garg S, Chauhan R, et al. Profile of chronic hepatitis B virus in children in India: Experience with 116 children. J Gastroenterol Hepatol 2006; 21: 1170-6.
37. Bruix J, Sherman M Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-36.